Literature DB >> 7602087

Prospects for hepatitis C vaccine.

A J Zuckerman1, J N Zuckerman.   

Abstract

The genetic and serological heterogeneity of hepatitis C virus and reinfections will make the development of a broad spectrum effective hepatitis C vaccine difficult. Important steps are identification of neutralising antibodies; reproducible techniques for tissue culture of HCV; the application of methods used for the development of vaccines against flaviviruses and pestiviruses, and the application of gene transfer techniques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602087

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study.

Authors:  J F Quarleri; B H Robertson; V L Mathet; M Feld; L Espínola; M P Requeijo; O Mandó; G Carballal; J R Oubiña
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 2.  Epidemiology of hepatitis C virus infection among injecting drug users in Australia.

Authors:  N Crofts; D Jolley; J Kaldor; I van Beek; A Wodak
Journal:  J Epidemiol Community Health       Date:  1997-12       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.